- Home
- ATOS vs FSP Comparison
ATOS vs FSP Comparison
Compare ATOS & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- FSP
- Stock Information
- Founded
- ATOS 2009
- FSP 1981
- Country
- ATOS United States
- FSP United States
- Employees
- ATOS N/A
- FSP N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- FSP Real Estate Investment Trusts
- Sector
- ATOS Health Care
- FSP Real Estate
- Exchange
- ATOS Nasdaq
- FSP Nasdaq
- Market Cap
- ATOS 174.8M
- FSP 178.1M
- IPO Year
- ATOS 2012
- FSP N/A
- Fundamental
- Price
- ATOS $1.47
- FSP $1.64
- Analyst Decision
- ATOS Strong Buy
- FSP
- Analyst Count
- ATOS 3
- FSP 0
- Target Price
- ATOS $6.25
- FSP N/A
- AVG Volume (30 Days)
- ATOS 575.2K
- FSP 342.4K
- Earning Date
- ATOS 11-12-2024
- FSP 11-05-2024
- Dividend Yield
- ATOS N/A
- FSP 2.43%
- EPS Growth
- ATOS N/A
- FSP N/A
- EPS
- ATOS N/A
- FSP N/A
- Revenue
- ATOS N/A
- FSP $133,729,000.00
- Revenue This Year
- ATOS N/A
- FSP N/A
- Revenue Next Year
- ATOS N/A
- FSP $0.02
- P/E Ratio
- ATOS N/A
- FSP N/A
- Revenue Growth
- ATOS N/A
- FSP N/A
- 52 Week Low
- ATOS $0.62
- FSP $1.47
- 52 Week High
- ATOS $2.31
- FSP $2.72
- Technical
- Relative Strength Index (RSI)
- ATOS 54.46
- FSP 45.06
- Support Level
- ATOS $1.40
- FSP $1.60
- Resistance Level
- ATOS $1.58
- FSP $1.77
- Average True Range (ATR)
- ATOS 0.08
- FSP 0.08
- MACD
- ATOS -0.00
- FSP -0.01
- Stochastic Oscillator
- ATOS 52.17
- FSP 18.18
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.